T-BSDB-H319 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem Diabody) |
Human |
|
DTPA |
GD2 |
Inquiry |
T-BSDB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem Diabody) |
Human |
|
DTPA |
GD2 |
Inquiry |
SCIGG-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
DTPA |
GD2 |
Inquiry |
FVTIG-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
DTPA |
GD2 |
Inquiry |
BSSG-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
DTPA |
GD2 |
Inquiry |
IGLFV-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
DTPA |
GD2 |
Inquiry |
BSGV-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
DTPA |
GD2 |
Inquiry |
BSDG-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
DTPA |
GD2 |
Inquiry |
BABFV-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
DTPA |
GD2 |
Inquiry |
FABVC-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
DTPA |
GD2 |
Inquiry |
SCDBC-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
DTPA |
GD2 |
Inquiry |
BSDBC-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
DTPA |
GD2 |
Inquiry |
SCDBF-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
DTPA |
GD2 |
Inquiry |
BSFVF-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
DTPA |
GD2 |
Inquiry |
BSDBF-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
DTPA |
GD2 |
Inquiry |
BSTF-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-Fc-scFv |
DTPA |
GD2 |
Inquiry |
BSCFV-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scFv-Fc) |
Human |
scFv-Fc |
DTPA |
GD2 |
Inquiry |
MNAB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Miniantibody) |
Human |
Miniantibody |
DTPA |
GD2 |
Inquiry |
BSFC-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scFv-CH3) |
Human |
scFv-CH3 |
DTPA |
GD2 |
Inquiry |
BSCC-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-CH1/CL |
DTPA |
GD2 |
Inquiry |
BIBD-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Bibody) |
Human |
Bibody |
DTPA |
GD2 |
Inquiry |
FABFV-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
DTPA |
GD2 |
Inquiry |
MiniB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Minibody) |
Human |
Minibody |
DTPA |
GD2 |
Inquiry |
SCDB-H319 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
DTPA |
GD2 |
Inquiry |
FABIG-H319 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
DTPA |
GD2 |
Inquiry |
TRIB-H321 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
DTPA |
GD2 |
Inquiry |
BSIG-H319 |
Human Anti-DTPA x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
DTPA |
GD2 |
Inquiry |
CROSSAB-H319 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
DTPA |
GD2 |
Inquiry |
IGFV-H319 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
DTPA |
GD2 |
Inquiry |
BSDB-H319 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
DTPA |
GD2 |
Inquiry |
BSFAB-H319 |
Recombinant Human Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
DTPA |
GD2 |
Inquiry |
SCDB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
DTPA |
GD2 |
Inquiry |
FABIG-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
DTPA |
GD2 |
Inquiry |
TRIB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
DTPA |
GD2 |
Inquiry |
BSIG-153 |
Anti-DTPA x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
DTPA |
GD2 |
Inquiry |
CROSSAB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
DTPA |
GD2 |
Inquiry |
IGFV-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
DTPA |
GD2 |
Inquiry |
BSDB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
DTPA |
GD2 |
Inquiry |
BSFAB-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
DTPA |
GD2 |
Inquiry |
BSFV-153 |
Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
DTPA |
GD2 |
Inquiry |
SCDB-H307 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CEA |
GD2 |
Inquiry |
SCDB-H298 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD64 |
GD2 |
Inquiry |
SCDB-H257 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD3 |
GD2 |
Inquiry |
SCDB-H212 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
GD2 |
Inquiry |
FABIG-H307 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CEA |
GD2 |
Inquiry |
FABIG-H298 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
GD2 |
Inquiry |
FABIG-H257 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD3 |
GD2 |
Inquiry |
FABIG-H212 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
GD2 |
Inquiry |
TRIB-H309 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CEA |
GD2 |
Inquiry |
TRIB-H300 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
GD2 |
Inquiry |
TRIB-H259 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD3 |
GD2 |
Inquiry |
TRIB-H214 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
GD2 |
Inquiry |
BSIG-H307 |
Human Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CEA |
GD2 |
Inquiry |
BSIG-H298 |
Human Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
GD2 |
Inquiry |
BSIG-H257 |
Human Anti-CD3 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD3 |
GD2 |
Inquiry |
BSIG-H212 |
Human Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
GD2 |
Inquiry |
CROSSAB-H307 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CEA |
GD2 |
Inquiry |
CROSSAB-H298 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
GD2 |
Inquiry |
CROSSAB-H257 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
GD2 |
Inquiry |
CROSSAB-H212 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
GD2 |
Inquiry |
IGFV-H307 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CEA |
GD2 |
Inquiry |
IGFV-H298 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
GD2 |
Inquiry |
IGFV-H257 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
GD2 |
Inquiry |
IGFV-H212 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
GD2 |
Inquiry |
BSDB-H307 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CEA |
GD2 |
Inquiry |
BSDB-H298 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
GD2 |
Inquiry |
BSDB-H257 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
GD2 |
Inquiry |
BSDB-H212 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
GD2 |
Inquiry |
BSFAB-H307 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CEA |
GD2 |
Inquiry |
BSFAB-H298 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
GD2 |
Inquiry |
BSFAB-H257 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
GD2 |
Inquiry |
BSFAB-H212 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
GD2 |
Inquiry |
BSFV-H307 |
Recombinant Human Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CEA |
GD2 |
Inquiry |
BSFV-H298 |
Recombinant Human Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
GD2 |
Inquiry |
BSFV-H257 |
Recombinant Human Anti-CD3 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
GD2 |
Inquiry |
BSFV-H212 |
Recombinant Human Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
GD2 |
Inquiry |
SCTB-094 |
Recombinant Anti-GD2 x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD64 |
GD2 |
Inquiry |
SCTB-056 |
Recombinant Anti-GD2 x Anti-CD3 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD3 |
GD2 |
Inquiry |
SCTB-013 |
Recombinant Anti-GD2 x Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
GD2 |
Inquiry |
SCDB-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CEA |
GD2 |
Inquiry |
SCDB-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CEA |
DTPA |
Inquiry |
SCDB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD64 |
GD2 |
Inquiry |
SCDB-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD3 |
GD2 |
Inquiry |
SCDB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
GD2 |
Inquiry |
FABIG-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CEA |
GD2 |
Inquiry |
FABIG-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CEA |
DTPA |
Inquiry |
FABIG-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
GD2 |
Inquiry |
FABIG-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD3 |
GD2 |
Inquiry |
FABIG-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
GD2 |
Inquiry |
TRIB-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CEA |
GD2 |
Inquiry |
TRIB-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CEA |
DTPA |
Inquiry |
TRIB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
GD2 |
Inquiry |
TRIB-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD3 |
GD2 |
Inquiry |
TRIB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
GD2 |
Inquiry |
BSIG-138 |
Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CEA |
GD2 |
Inquiry |
BSIG-137 |
Anti-CEA x Anti-DTPA Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CEA |
DTPA |
Inquiry |
BSIG-126 |
Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
GD2 |
Inquiry |
BSIG-083 |
Anti-CD3 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD3 |
GD2 |
Inquiry |
BSIG-037 |
Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
GD2 |
Inquiry |
CROSSAB-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CEA |
GD2 |
Inquiry |
CROSSAB-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CEA |
DTPA |
Inquiry |
CROSSAB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
GD2 |
Inquiry |
CROSSAB-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
GD2 |
Inquiry |
CROSSAB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
GD2 |
Inquiry |
IGFV-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CEA |
GD2 |
Inquiry |
IGFV-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CEA |
DTPA |
Inquiry |
IGFV-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
GD2 |
Inquiry |
IGFV-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
GD2 |
Inquiry |
IGFV-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
GD2 |
Inquiry |
BSDB-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CEA |
GD2 |
Inquiry |
BSDB-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (Diabody) |
Human |
Diabody |
CEA |
DTPA |
Inquiry |
BSDB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
GD2 |
Inquiry |
BSDB-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
GD2 |
Inquiry |
BSDB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
GD2 |
Inquiry |
BSFAB-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CEA |
GD2 |
Inquiry |
BSFAB-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CEA |
DTPA |
Inquiry |
BSFAB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
GD2 |
Inquiry |
BSFAB-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
GD2 |
Inquiry |
BSFAB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
GD2 |
Inquiry |
BSFV-138 |
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CEA |
GD2 |
Inquiry |
BSFV-137 |
Recombinant Anti-CEA x Anti-DTPA Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CEA |
DTPA |
Inquiry |
BSFV-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
GD2 |
Inquiry |
BSFV-083 |
Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
GD2 |
Inquiry |
BSFV-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
GD2 |
Inquiry |